secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-07-24T23:59:59+00:00
Accession:  0001683168-24-005023
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals gets final Nasdaq extension to Aug 12 for equity compliance
-------------------------------------------------------------------------------

- Nasdaq Panel granted extension until August 12, 2024 to meet $2.5M stockholders' equity requirement.
- Company previously failed to comply with Listing Rule 5550(b) and requested hearing.
- This is the full extent of the Panel's discretion; failure to comply may lead to delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824005023/0001683168-24-005023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824005023/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-005023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer